M
Marc Carrier
Researcher at Ottawa Hospital Research Institute
Publications - 396
Citations - 17092
Marc Carrier is an academic researcher from Ottawa Hospital Research Institute. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 58, co-authored 325 publications receiving 12428 citations. Previous affiliations of Marc Carrier include Ottawa Hospital & University of Ottawa.
Papers
More filters
Journal ArticleDOI
VIDAS D-dimer in combination with clinical pre-test probability to rule out pulmonary embolism. A systematic review of management outcome studies.
Marc Carrier,Marc Philip Righini,Reza Karami Djurabi,Menno V. Huisman,Arnaud Perrier,Philip S. Wells,Marc A. Rodger,Walter A. Wuillemin,Grégoire Le Gal +8 more
TL;DR: The combination of a negative VIDAS D-dimer result and a non-high PTP effectively and safely excludes PE in an important proportion of outpatients with suspected PE.
Journal ArticleDOI
Rates of venous thromboembolism in multiple myeloma patients undergoing immunomodulatory therapy with thalidomide or lenalidomide: a systematic review and meta‐analysis
TL;DR: The benefit of various types of thromboprophylaxis is difficult to quantify in patients with MM receiving immunomodulatory therapy, especially in those receiving lenalidomide‐based therapy or who have previously treated MM.
Journal ArticleDOI
Aspirin Versus Low-Molecular-Weight Heparin for Extended Venous Thromboembolism Prophylaxis After Total Hip Arthroplasty: A Randomized Trial
David R. Anderson,Michael J. Dunbar,Eric Bohm,Etienne L. Belzile,Susan R. Kahn,David J. Zukor,William A. Fisher,Wade Gofton,Peter L. Gross,Stéphane Pelet,Mark Crowther,Steven J. MacDonald,Paul Y. Kim,Susan Pleasance,Nicki Davis,Pantelis Andreou,Philip S. Wells,Michael J. Kovacs,Marc A. Rodger,Tim Ramsay,Marc Carrier,Pascal-André Vendittoli +21 more
TL;DR: Extended prophylaxis for 28 days with aspirin was noninferior to and as safe as dalteparin for the prevention of VTE after THA in patients who initially received daltEParin for 10 days.
Journal ArticleDOI
The association between antiphospholipid antibodies and placenta mediated complications: A systematic review and meta-analysis
TL;DR: APLAs appear to be associated with late fetal losses, however, the association between APLAs and other placenta mediated complications is inconsistent and there is currently insufficient data to support a significant link between anti-B2 GP1 antibodies and pregnancy morbidity.
Journal ArticleDOI
Management of challenging cases of patients with cancer-associated thrombosis including recurrent thrombosis and bleeding: guidance from the SSC of the ISTH.
TL;DR: This work presents a meta-analyses of Hemostasis and Thrombosis during the first trimester of pregnancy and shows clear patterns of prognosis for meningitis and organ prolapse preoperatively and during the second trimester, which are related to sepsis.